Compare LVRO & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LVRO | EDAP |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | Brazil | France |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.5M | 137.6M |
| IPO Year | N/A | 1997 |
| Metric | LVRO | EDAP |
|---|---|---|
| Price | $0.99 | $4.90 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.88 | ★ $8.50 |
| AVG Volume (30 Days) | 86.8K | ★ 94.0K |
| Earning Date | 03-09-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,346,609,973.00 | $74,853,925.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.45 | $7.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.61 |
| 52 Week Low | $0.19 | $1.21 |
| 52 Week High | $5.40 | $5.05 |
| Indicator | LVRO | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 62.96 |
| Support Level | $1.04 | $4.17 |
| Resistance Level | $1.18 | $5.05 |
| Average True Range (ATR) | 0.08 | 0.39 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 13.32 | 76.72 |
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers, and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.